{"id":12056,"date":"2026-10-21T14:41:42","date_gmt":"2026-10-21T18:41:42","guid":{"rendered":"https:\/\/crassulapharma.com\/?page_id=12056"},"modified":"2026-10-21T15:19:00","modified_gmt":"2026-10-21T19:19:00","slug":"vascutan-plus","status":"publish","type":"page","link":"https:\/\/crassulapharma.com\/es\/vascutan-plus\/","title":{"rendered":"Vascutan Plus"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"12056\" class=\"elementor elementor-12056\" data-elementor-post-type=\"page\">\n\t\t\t\t<div class=\"elementor-element elementor-element-08c5c94 e-con-full e-flex e-con e-parent\" data-id=\"08c5c94\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t<div class=\"elementor-element elementor-element-499cd5f elementor-widget elementor-widget-html\" data-id=\"499cd5f\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"html.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<!doctype html>\n<html lang=\"en\">\n<head>\n<meta charset=\"utf-8\">\n<meta name=\"viewport\" content=\"width=device-width, initial-scale=1\">\n<title>Vascutan Plus\u00ae (Irbesartan \/ Hydrochlorothiazide) \u2013 Crassula<\/title>\n<meta name=\"description\" content=\"Vascutan Plus combines the Irbesartan and Hydrochlorothiazide molecules in a tablet for oral administration, designed to optimize blood pressure control in patients with hypertension who have not responded sufficiently to a single drug.\">\n<link rel=\"preload\" href=\"fonts\/poppins-latin-600-normal.woff2\" as=\"font\" type=\"font\/woff2\" crossorigin>\n<link rel=\"preload\" href=\"fonts\/ibm-plex-sans-latin-400-normal.woff2\" as=\"font\" type=\"font\/woff2\" crossorigin>\n<style>\n@font-face{font-family:\"Poppins\";font-weight:500;font-style:normal;font-display:swap;src:url(fonts\/poppins-latin-500-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"Poppins\";font-weight:600;font-style:normal;font-display:swap;src:url(fonts\/poppins-latin-600-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"IBM Plex Sans\";font-weight:400;font-style:normal;font-display:swap;src:url(fonts\/ibm-plex-sans-latin-400-normal.woff2) format(\"woff2\")}\n@font-face{font-family:\"IBM Plex Sans\";font-weight:500;font-style:normal;font-display:swap;src:url(fonts\/ibm-plex-sans-latin-500-normal.woff2) format(\"woff2\")}\n\n:root{\n  --teal-deep:#0e1e3e; --teal-head:#264a8a; --teal:#2d4f96; --teal-2:#5b82c4; --teal-3:#1a3266;\n  --red:#a4b52a; --accent-text:#6f7c1f; --green:#5ba646;\n  --action-teal:#2d4f96; --ink:#1b2433; --ink-muted:#4a5a70; --surface:#f3f7fa; --note:#f3f7fa;\n  --line:#dce6ee;\n  --ease-out:cubic-bezier(.23,1,.32,1);\n  --font-head:\"Poppins\",system-ui,sans-serif;\n  --font-body:\"IBM Plex Sans\",system-ui,sans-serif;\n  --cx-gutter:clamp(20px,5vw,48px);\n  --cx-max:1120px;\n}\n*{box-sizing:border-box;margin:0}\nhtml{scroll-behavior:smooth;scroll-padding-top:24px;-webkit-text-size-adjust:100%}\nbody{font-family:var(--font-body);font-size:17px;line-height:1.6;color:var(--ink);background:#fff;-webkit-font-smoothing:antialiased;text-rendering:optimizeLegibility}\nimg{max-width:100%;height:auto;display:block}\na{color:var(--action-teal)}\n:focus-visible{outline:2px solid var(--action-teal);outline-offset:2px;border-radius:6px}\n.skip{position:absolute;left:12px;top:-60px;background:var(--ink);color:#fff;padding:10px 16px;border-radius:999px;z-index:100;text-decoration:none;font-family:var(--font-head);font-weight:500}\n.skip:focus{top:12px}\n.cx-wrap{width:100%;max-width:var(--cx-max);margin-inline:auto;padding-inline:var(--cx-gutter)}\n\n\/* Buttons *\/\n.btn{white-space:nowrap;display:inline-flex;align-items:center;justify-content:center;gap:8px;min-height:48px;padding:16px 28px;border-radius:6px;font:500 16px\/1 var(--font-head);text-decoration:none;cursor:pointer;border:1.5px solid transparent;\n  transition:background-color 150ms var(--ease-out),transform 150ms var(--ease-out),box-shadow 150ms var(--ease-out),color 150ms var(--ease-out)}\n.btn:active{transform:scale(.97)}\n.btn-primary{background:#fff;color:var(--teal-deep)}\n.btn-secondary{background:transparent;border-color:rgba(255,255,255,.85);color:#fff}\n.btn-sm{padding:12px 22px;min-height:48px;font-size:15px}\n@media (hover:hover) and (pointer:fine){\n  .btn-primary:hover{background:#e3ecf5;transform:translateY(-2px)}\n  .btn-secondary:hover{background:#fff;color:var(--teal-deep);transform:translateY(-2px)}\n}\n\n\/* Hero *\/\n.hero{position:relative;background:linear-gradient(125deg,#0e1e3e 0%,#223f7a 50%,#7899d0 100%);overflow:hidden;isolation:isolate;color:#fff}\n.hero::before{content:\"\";position:absolute;inset:0;z-index:-1;background:repeating-linear-gradient(115deg,rgba(255,255,255,.045) 0 1px,transparent 1px 46px)}\n.hero canvas{position:absolute;inset:0;width:100%;height:100%;z-index:-1;pointer-events:none}\n.hero::after{content:\"\";position:absolute;left:-6%;right:-6%;bottom:-1px;height:clamp(36px,6vw,70px);background:#fff;border-radius:50% 50% 0 0\/100% 100% 0 0}\n.hero .cx-wrap{display:grid;grid-template-columns:1fr 1fr;align-items:center;gap:clamp(24px,4vw,48px);padding-block:clamp(50px,8vw,50px) clamp(96px,11vw,132px)}\n.tag{display:inline-block;font:500 12px\/1 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:#fff;border:1px solid rgba(255,255,255,.4);border-radius:6px;padding:11px 16px;background:rgba(255,255,255,.08);margin-bottom:28px}\nh1{font:600 clamp(40px,7vw,64px)\/1.08 var(--font-head);letter-spacing:-.02em;color:#fff}\nh1 sup{font-size:.34em;vertical-align:top;position:relative;top:.55em;margin-left:.08em;letter-spacing:0}\n.generic{font:500 clamp(22px,3vw,28px)\/1.3 var(--font-head);color:rgba(255,255,255,.88);margin-top:10px}\n.strengths{display:flex;gap:10px;margin-top:26px;flex-wrap:wrap}\n.chip{font:600 20px\/1 var(--font-head);padding:12px 20px;border-radius:12px;color:#fff;font-variant-numeric:tabular-nums}\n.chip.t{background:#fff;color:var(--teal-head)}.chip.g{background:var(--red)}\n.cta-row{display:flex;gap:12px;flex-wrap:wrap;margin-top:36px}\n.hero-art{position:relative;aspect-ratio:1.08\/1;width:110%;margin-right:-10%}\n.hero-art img{position:absolute}\n.hero-art .a{left:0;top:18%;width:56%}\n.hero-art .b{right:0;top:38%;width:62%}\n@media (max-width:860px){.hero .cx-wrap{grid-template-columns:1fr}.hero-art{max-width:600px;width:100%;margin:0 auto}}\n\n\/* Spec strip *\/\n.specs{margin-top:-70px;position:relative;z-index:2}\n.specs ul{list-style:none;padding:0;display:grid;grid-template-columns:repeat(4,1fr);background:#fff;border:1px solid var(--line);border-radius:20px;box-shadow:0 14px 34px -18px rgba(14,30,62,.30)}\n.specs ul{overflow:hidden}\n.specs li{position:relative;transition:background-color 250ms var(--ease-out),transform 250ms var(--ease-out);display:flex;align-items:center;gap:14px;padding:22px 24px;border-left:1px solid var(--line)}\n.specs li:first-child{border-left:0}\n.specs li::after{content:\"\";position:absolute;left:0;right:0;bottom:0;height:3px;background:linear-gradient(90deg,var(--teal-2),var(--green));transform:scaleX(0);transform-origin:left;transition:transform 350ms var(--ease-out)}\n.specs .ico{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out),box-shadow 300ms var(--ease-out)}\n.specs dd{transition:transform 300ms var(--ease-out),color 250ms var(--ease-out)}\n@media (hover:hover){\n  .specs li:hover{background:var(--note)}\n  .specs li:hover::after{transform:scaleX(1)}\n  .specs li:hover .ico{transform:translateY(-3px) scale(1.12) rotate(-6deg);background:var(--teal-deep);box-shadow:0 10px 18px -8px rgba(14,30,62,.55)}\n  .specs li:hover dd{color:var(--teal);transform:translateX(3px)}\n}\n.ico{flex:none;width:42px;height:42px;border-radius:50%;background:var(--action-teal);display:grid;place-items:center;color:#fff}\n.ico svg{width:20px;height:20px;stroke:currentColor;fill:none;stroke-width:1.8;stroke-linecap:round;stroke-linejoin:round}\n.specs dt{font:500 11px\/1.2 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:var(--ink-muted)}\n.specs dd{font:600 15.5px\/1.3 var(--font-head);margin-top:4px;color:var(--ink)}\n@media (max-width:900px){.specs ul{grid-template-columns:1fr 1fr}.specs li:nth-child(3){border-left:0}.specs li:nth-child(n+3){border-top:1px solid var(--line)}}\n@media (max-width:480px){.specs ul{grid-template-columns:1fr}.specs li{border-left:0!important}.specs li+li{border-top:1px solid var(--line)}}\n\n\/* Sections *\/\nsection{padding-block:clamp(56px,8vw,96px)}\n.h2{color:var(--teal-head);display:flex;align-items:center;gap:14px;font:600 clamp(28px,4vw,36px)\/1.15 var(--font-head);letter-spacing:-.01em;margin-bottom:28px}\n.h2::before{content:\"\";flex:none;width:6px;align-self:stretch;min-height:1.1em;border-radius:4px;background:linear-gradient(var(--teal-2),var(--green))}\n.prose p{max-width:68ch;color:var(--ink)}\n.prose p+p{margin-top:14px}\n.prose strong{font-weight:500;color:var(--action-teal);font-family:var(--font-head)}\n.about{padding-top:clamp(64px,9vw,104px)}\n\n\/* Indications *\/\n.indications{background:#fff;padding-top:0}\n.cards{display:grid;grid-template-columns:repeat(2,1fr);gap:20px}\n.card{background:var(--surface);border:1px solid var(--line);border-radius:20px;padding:28px;transition:transform 250ms var(--ease-out),box-shadow 250ms var(--ease-out),border-color 250ms var(--ease-out)}\n.card{position:relative;overflow:hidden}\n.card::after{content:\"\";position:absolute;left:0;right:0;bottom:0;height:4px;background:linear-gradient(90deg,var(--teal-2),var(--green));transform:scaleX(0);transform-origin:left;transition:transform 400ms var(--ease-out)}\n.card .ico{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out),color 250ms var(--ease-out)}\n@media (hover:hover){\n  .card:hover{transform:translateY(-8px);box-shadow:0 24px 40px -22px rgba(14,30,62,.45);border-color:#a9bfd8;background:#fff}\n  .card:hover::after{transform:scaleX(1)}\n  .card:hover .ico{background:var(--teal);color:#fff;transform:rotate(-8deg) scale(1.12)}\n}\n.card .ico{width:38px;height:38px;background:#fff;color:var(--action-teal);border:1px solid var(--line);border-radius:12px;margin-bottom:18px}\n.card h3{color:var(--teal-head);font:600 19px\/1.3 var(--font-head);color:var(--ink);margin-bottom:10px}\n.card p{color:var(--ink-muted);font-size:16.5px}\n.card em{font-style:italic}\n@media (max-width:760px){.cards{grid-template-columns:1fr}}\n\n\/* Presentations *\/\n.presentations{background:var(--surface)}\n.pres{display:grid;grid-template-columns:1fr 1fr;gap:20px}\n.pcard{display:flex;align-items:center;gap:24px;background:#fff;border:1px solid var(--line);border-radius:20px;padding:26px 28px;position:relative;overflow:hidden;transition:transform 250ms var(--ease-out),box-shadow 250ms var(--ease-out)}\n.pcard::before{content:\"\";position:absolute;left:0;top:0;bottom:0;width:6px;background:var(--c)}\n.pcard::before{transition:width 300ms var(--ease-out)}\n.dose{transition:transform 350ms var(--ease-out)}\n@media (hover:hover){\n  .pcard:hover{transform:translateY(-6px);box-shadow:0 24px 40px -22px rgba(14,30,62,.45)}\n  .pcard:hover::before{width:14px}\n  .pcard:hover .dose{transform:scale(1.08) translateX(4px)}\n}\n.dose{font:600 clamp(40px,6vw,52px)\/1 var(--font-head);color:var(--c);letter-spacing:-.02em;white-space:nowrap}\n.dose small{font:500 18px\/1 var(--font-head);letter-spacing:0;margin-left:4px}\n.pcard h3{color:var(--teal-head);font:600 17px\/1.35 var(--font-head);margin-bottom:6px}\n.pcard p{color:var(--ink-muted);font-size:16px;line-height:1.5}\n@media (max-width:760px){.pres{grid-template-columns:1fr}}\n\n\/* Mechanism *\/\n.mech-intro{max-width:78ch;margin-bottom:44px}\n.mech-intro strong{font-weight:500;color:var(--action-teal);font-family:var(--font-head)}\n.mech-grid{display:grid;grid-template-columns:1.1fr .9fr;gap:clamp(28px,5vw,64px);align-items:start}\n.steps{list-style:none;padding:0;position:relative}\n.steps::before{content:\"\";position:absolute;left:19px;top:20px;bottom:30px;width:2px;background:linear-gradient(var(--action-teal),rgba(45,79,150,.08));transform-origin:top;transform:scaleY(var(--line,0));transition:transform 900ms var(--ease-out)}\n.steps li{position:relative;padding-left:64px;padding-bottom:34px;transition:transform 300ms var(--ease-out)}\n.num{transition:transform 300ms var(--ease-out),background-color 250ms var(--ease-out)}\n.steps h3{transition:color 250ms var(--ease-out)}\n@media (hover:hover){.steps li:hover{transform:translateX(6px)}.steps li:hover .num{transform:scale(1.18);background:var(--teal-deep)}.steps li:hover h3{color:var(--teal)}}\n.steps li:last-child{padding-bottom:0}\n.num{position:absolute;left:0;top:0;width:40px;height:40px;border-radius:50%;background:var(--action-teal);color:#fff;display:grid;place-items:center;font:600 16px\/1 var(--font-head);box-shadow:0 0 0 5px #fff}\n.steps h3{color:var(--teal-head);font:600 19px\/1.3 var(--font-head);color:var(--ink);margin:6px 0 6px}\n.steps p{color:var(--ink-muted)}\n@media (max-width:900px){.mech-grid{grid-template-columns:1fr}}\n\n\/* Flow diagram *\/\n.flow{background:var(--surface);border:1px solid var(--line);border-radius:24px;padding:28px clamp(18px,3vw,32px) 32px;text-align:center}\n.flow-title{font:600 12px\/1 var(--font-body);letter-spacing:.14em;text-transform:uppercase;color:var(--ink-muted);margin-bottom:22px}\n.node{display:block;margin-inline:auto;background:#fff;border:1.5px solid #c5d5e6;border-radius:12px;padding:10px 16px;max-width:300px;font:600 14px\/1.3 var(--font-head);color:var(--ink);opacity:0;transition:border-color 250ms var(--ease-out),box-shadow 250ms var(--ease-out),transform 250ms var(--ease-out)}\n.node small{display:block;font:400 12px\/1.3 var(--font-body);color:var(--ink-muted);margin-top:2px}\n.node.primary{background:var(--action-teal);border-color:var(--action-teal);color:#fff;border-radius:999px;padding:14px 20px;font-size:16px}\n.node.primary small{color:#fff;font-size:12.5px}\n.node.end{background:var(--action-teal);border-color:var(--action-teal);color:#fff;padding:14px 18px;font-size:15px}\n.flow.in .node{opacity:1;animation:rise 450ms var(--ease-out) backwards;animation-delay:calc(var(--i)*220ms)}\n@media (hover:hover){.flow.in .node:hover{transform:translateY(-3px) scale(1.03);border-color:var(--teal);box-shadow:0 10px 20px -12px rgba(14,30,62,.45)}}\n.link-v{display:flex;flex-direction:column;align-items:center;height:30px;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .link-v{opacity:1}\n.link-v::before{content:\"\";flex:1;width:2px;background:var(--action-teal)}\n.link-v::after{content:\"\";width:0;height:0;border:6px solid transparent;border-top:8px solid var(--action-teal);border-bottom:0}\n.link-v.stop::after{border:0;width:22px;height:2px;background:var(--red)}\n.link-v.stop::before{background:var(--red)}\n.link-v.stop span{position:absolute;left:calc(50% + 14px);top:50%;transform:translateY(-50%);font:400 11.5px\/1 var(--font-body);color:var(--accent-text)}\n.pair{display:grid;grid-template-columns:1fr 1fr;gap:10px;max-width:340px;margin-inline:auto}\n.pair .node{max-width:none;font-size:13px;padding:10px 10px}\n.fork{max-width:340px;height:28px;margin-inline:auto;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .fork{opacity:1}\n.fork::before{content:\"\";position:absolute;left:25%;right:25%;top:0;height:14px;border:2px solid var(--action-teal);border-bottom:0;border-radius:0}\n.fork::after{content:\"\";position:absolute;left:50%;top:-14px;height:14px;width:2px;background:var(--action-teal)}\n.fork i{position:absolute;top:14px;width:0;height:0;border:6px solid transparent;border-top:8px solid var(--action-teal);border-bottom:0}\n.fork i:first-child{left:calc(25% - 6px)}.fork i:last-child{right:calc(25% - 6px)}\n.pair-wrap{display:grid;gap:10px}\n.down-merge{margin-top:2px}\n\n\n\/* Product additions *\/\n.pcard.wide{display:grid;grid-template-columns:auto 1fr;gap:clamp(20px,4vw,48px)}\n.pgrid{display:grid;grid-template-columns:repeat(3,1fr);gap:20px}\n.pgrid dt{font:500 11px\/1.2 var(--font-body);letter-spacing:.12em;text-transform:uppercase;color:var(--ink-muted)}\n.pgrid dd{font:600 16px\/1.35 var(--font-head);color:var(--teal-head);margin-top:6px}\n@media (max-width:760px){.pcard.wide{grid-template-columns:1fr;gap:16px}.pgrid{grid-template-columns:1fr}}\n.dn{color:var(--red);font-weight:600}\n.node.end.clock{display:flex;align-items:center;justify-content:center;gap:12px;max-width:260px;margin-top:14px;text-align:left;padding:12px 18px}\n.node.end.clock svg{flex:none;width:34px;height:34px;padding:7px;border-radius:50%;background:var(--red);stroke:#fff;fill:none;stroke-width:2;stroke-linecap:round;stroke-linejoin:round}\n.node.end.clock b{display:block;font:600 15px\/1.2 var(--font-head)}\n.node.end.clock small{color:#fff;opacity:.92;font-size:12px;margin-top:2px}\n.pair{margin-top:0}\n.steps p sup{font-size:.7em;line-height:0}\n\n\n\/* Media + FAQ additions *\/\n.split{display:grid;grid-template-columns:1.1fr .9fr;gap:clamp(28px,5vw,72px);align-items:center}\n.split.rev{grid-template-columns:.9fr 1.1fr}\n.media-wrap{position:relative;isolation:isolate}\n.media-wrap::before{content:\"\";position:absolute;right:-14px;bottom:-14px;width:62%;height:62%;border-radius:26px;background:linear-gradient(135deg,var(--teal-2),var(--green));opacity:.2;z-index:-1;transition:transform 500ms var(--ease-out),opacity 500ms var(--ease-out)}\n.split.rev .media-wrap::before{right:auto;left:-14px}\n.media{position:relative;border-radius:24px;overflow:hidden;aspect-ratio:4\/4;background:var(--surface)}\n.media img{width:100%;height:100%;object-fit:cover;display:block;transition:transform 900ms var(--ease-out)}\n@media (hover:hover){.media-wrap:hover .media img{transform:scale(1.05)}.media-wrap:hover::before{transform:translate(6px,6px);opacity:.32}.split.rev .media-wrap:hover::before{transform:translate(-6px,6px)}}\n@media (max-width:860px){.split,.split.rev{grid-template-columns:1fr}.split.rev .media-wrap{order:2}.media-wrap{max-width:560px}}\n.faq{background:var(--surface)}\n.faq-list{display:grid;gap:12px;max-width:880px}\n.faq-item{background:#fff;border:1px solid var(--line);border-radius:16px;overflow:hidden;transition:border-color 250ms var(--ease-out),box-shadow 250ms var(--ease-out),transform 250ms var(--ease-out)}\n@media (hover:hover){.faq-item:hover{transform:translateY(-2px);border-color:#a9bfd8;border-color:color-mix(in srgb,var(--teal-2) 40%,var(--line));box-shadow:0 16px 30px -22px rgba(14,30,62,.4)}}\n.faq-item.open{border-color:var(--teal-2);box-shadow:0 18px 34px -24px rgba(14,30,62,.45)}\n.faq-q{width:100%;display:flex;align-items:center;justify-content:space-between;gap:16px;min-height:48px;padding:20px 24px;background:none;border:0;cursor:pointer;text-align:left;font:600 17px\/1.4 var(--font-head);color:var(--teal-head)}\n.faq-q:focus-visible{outline-offset:-4px}\n.faq-ico{flex:none;width:34px;height:34px;border-radius:10px;background:var(--surface);display:grid;place-items:center;transition:background-color 250ms var(--ease-out),transform 350ms var(--ease-out)}\n.faq-ico svg{width:16px;height:16px;stroke:var(--teal);stroke-width:2.2;stroke-linecap:round;fill:none;transition:stroke 250ms var(--ease-out)}\n.faq-item.open .faq-ico{background:var(--teal);transform:rotate(45deg)}\n.faq-item.open .faq-ico svg{stroke:#fff}\n.faq-a{display:grid;grid-template-rows:0fr;transition:grid-template-rows 350ms var(--ease-out)}\n.faq-item.open .faq-a{grid-template-rows:1fr}\n.faq-a>div{overflow:hidden;visibility:hidden;transition:visibility 0s linear 350ms}\n.faq-item.open .faq-a>div{visibility:visible;transition-delay:0s}\n.faq-a p{padding:0 24px 22px;max-width:70ch;color:var(--ink-muted)}\n.faq-a p+p{padding-top:0;margin-top:-8px}\n\n\n\/* Note with background image *\/\n.note-box.has-bg{position:relative;overflow:hidden;isolation:isolate;border:0;color:#fff;min-height:260px;display:flex;flex-direction:column;justify-content:center;padding:clamp(32px,5vw,64px)}\n.note-box.has-bg .bg{position:absolute;inset:0;z-index:-2;overflow:hidden}\n.note-box.has-bg .bg img{width:100%;height:100%;object-fit:cover;object-position:0% 100%;display:block;transform:scale(1.02);transition:transform 1000ms var(--ease-out)}\n.note-box.has-bg::after{content:\"\";position:absolute;inset:0;z-index:-1;background:linear-gradient(100deg,rgba(var(--ov),.93) 0%,rgba(var(--ov),.86) 60%,rgba(var(--ov),.78) 100%)}\n.note-box.has-bg h3{color:#fff}\n.note-box.has-bg h3 .ico{background:rgba(255,255,255,.16);box-shadow:inset 0 0 0 1px rgba(255,255,255,.28)}\n.note-box.has-bg p{color:#fff;max-width:72ch;font-size:17.5px}\n.note-box.has-bg p::before{background:var(--green)}\n@media (hover:hover){.note-box.has-bg:hover .bg img{transform:scale(1.08)}}\n\/* Rounded-corner fix: clip every layer to the radius so hover scale never squares the corners *\/\n.note-box.has-bg{border-radius:20px;clip-path:inset(0 round 20px)}\n@media (hover:hover){.note-box.has-bg:hover{transform:translate3d(0,-4px,0);box-shadow:none}}\n.note-box.has-bg .bg,.note-box.has-bg .bg img,.note-box.has-bg::after{border-radius:20px}\n.note-box.has-bg .bg img{will-change:transform}\n\n\n\/* Note *\/\n.note{padding-block:0 clamp(40px,6vw,64px)}\n.note-box{background:var(--note);border:1px solid #dce6ee;border-radius:20px;padding:26px clamp(20px,3vw,32px)}\n.note-box{transition:transform 300ms var(--ease-out),box-shadow 300ms var(--ease-out)}\n@media (hover:hover){.note-box:hover{transform:translateY(-4px);box-shadow:0 22px 38px -26px rgba(14,30,62,.5)}}\n.note-box h3{color:var(--teal-head);display:flex;align-items:center;gap:12px;font:600 19px\/1.2 var(--font-head);margin-bottom:12px}\n.note-box h3 .ico{width:38px;height:38px;border-radius:12px;background:var(--action-teal)}\n.note-box p{position:relative;padding-left:20px;color:var(--ink)}\n.note-box p::before{content:\"\";position:absolute;left:0;top:.7em;width:8px;height:8px;border-radius:50%;background:var(--teal-2)}\n\n\/* Quality *\/\n.quality{padding-top:96px}\n.qbox{border:1px solid var(--line);border-radius:20px;padding:clamp(22px,3vw,34px);box-shadow:0 14px 34px -24px rgba(14,42,51,.25)}\n.qbox h2{font:600 22px\/1.2 var(--font-head);margin-bottom:24px}\n.qgrid{display:grid;grid-template-columns:auto 1fr 1fr;gap:clamp(20px,3vw,40px);align-items:center}\n.gmp{width:112px;height:112px;object-fit:contain;flex:none;filter:drop-shadow(0 6px 12px rgba(14,30,62,.18));transition:transform 500ms var(--ease-out),filter 500ms var(--ease-out)}\n@media (hover:hover){.gmp:hover{transform:scale(1.08);filter:drop-shadow(0 10px 18px rgba(14,30,62,.24))}}\n.check{display:flex;gap:14px;color:var(--ink-muted);font-size:16px;line-height:1.55}\n.check{transition:transform 300ms var(--ease-out)}\n@media (hover:hover){.check:hover{transform:translateY(-4px)}.check:hover svg{transform:scale(1.18) rotate(-6deg)}}\n.check svg{transition:transform 300ms var(--ease-out);flex:none;width:26px;height:26px;stroke:var(--green);fill:none;stroke-width:1.8;stroke-linecap:round;stroke-linejoin:round;margin-top:2px}\n@media (max-width:900px){.qgrid{grid-template-columns:1fr;align-items:start}}\n\n\/* Reveal *\/\n.rv{opacity:0}\n.rv.in{opacity:1;animation:rise 600ms var(--ease-out) backwards;animation-delay:calc(var(--d,0)*80ms)}\n@keyframes rise{from{opacity:0;transform:translateY(18px)}to{opacity:1;transform:none}}\n.hero-art img{opacity:0;transition:opacity 700ms var(--ease-out),transform 900ms var(--ease-out)}\n.loaded .hero-art img{opacity:1;transform:none}\n@keyframes bob{0%,100%{translate:0 0}50%{translate:0 -8px}}\n.hero-art .a{transform:translate(-36px,18px) rotate(-3deg)}\n.hero-art .b{transform:translate(40px,28px) rotate(2deg)}\n.loaded .hero-art .b{transition-delay:150ms}\n.loaded .hero-art .a{animation:bob 7s ease-in-out 1.2s infinite}\n.loaded .hero-art .b{animation:bob 7s ease-in-out 2.4s infinite}\n.hero-copy>*{opacity:0;transform:translateY(14px);transition:opacity 600ms var(--ease-out),transform 600ms var(--ease-out)}\n.loaded .hero-copy>*{opacity:1;transform:none}\n.loaded .hero-copy>:nth-child(2){transition-delay:70ms}.loaded .hero-copy>:nth-child(3){transition-delay:140ms}.loaded .hero-copy>:nth-child(4){transition-delay:210ms}.loaded .hero-copy>:nth-child(5){transition-delay:280ms}\n\n@media (prefers-reduced-motion:reduce){\n  html{scroll-behavior:auto}\n  *,*::before,*::after{animation:none!important;transition-duration:.01ms!important;transition-delay:0ms!important}\n  .rv,.hero-copy>*,.hero-art img,.node,.link-v,.fork,.join{opacity:1!important;transform:none!important}\n  .steps{--line:1!important}\n}\n.no-js .rv,.no-js .hero-copy>*,.no-js .hero-art img,.no-js .node,.no-js .link-v,.no-js .fork,.no-js .join{opacity:1;transform:none}\n.no-js .steps{--line:1}\n\n\/* Vascutan Plus additions *\/\n.chip.g{background:#ccdb44;color:#2f3a06}\n.cards.c3{grid-template-columns:repeat(3,1fr)}\n@media (max-width:900px){.cards.c3{grid-template-columns:1fr}}\n.card-h{display:flex;align-items:center;gap:14px;margin-bottom:10px}\n.card-h .ico{margin-bottom:0;flex:none}\n.card-h h3{margin-bottom:0}\n.lead{max-width:80ch;margin-bottom:28px;color:var(--ink)}\n.cards.c2{margin-bottom:20px}\n.cards.c2 .card.wide{grid-column:1\/-1}\n.card ul{list-style:none;padding:0;display:grid;gap:10px}\n.card li{position:relative;padding-left:20px;color:var(--ink-muted);font-size:16.5px}\n.card li::before{content:\"\";position:absolute;left:0;top:.65em;width:8px;height:8px;border-radius:50%;background:var(--teal-2)}\n.card.wide ul{grid-template-columns:repeat(3,1fr);gap:18px 28px}\n@media (max-width:900px){.card.wide ul{grid-template-columns:1fr}}\n.pcard{flex-wrap:wrap}\n.pcard .dose{font-size:clamp(34px,4.5vw,44px)}\n.pcard h3{font-size:16px}\n.pcard.a2{--c:#9aab1f}\n.cols{display:grid;grid-template-columns:1fr 1fr;gap:12px;max-width:360px;margin-inline:auto}\n.col{display:flex;flex-direction:column;align-items:stretch}\n.col .node{max-width:none;width:100%;font-size:13px;padding:9px 8px}\n.col .node small{font-size:11px}\n.col .link-v{height:26px;flex:none}\n.node.lime{background:#ccdb44;border-color:#ccdb44;color:#2f3a06;border-radius:999px;padding:9px 8px}\n.node.blue{background:var(--action-teal);border-color:var(--action-teal);color:#fff;border-radius:999px;padding:9px 8px}\n.join{max-width:360px;height:16px;margin-inline:auto;position:relative;opacity:0;transition:opacity 400ms var(--ease-out);transition-delay:calc(var(--i)*220ms)}\n.flow.in .join{opacity:1}\n.join::before{content:\"\";position:absolute;left:25%;right:25%;bottom:0;height:16px;border:2px solid var(--action-teal);border-top:0}\n.join::after{content:\"\";position:absolute;left:50%;bottom:-14px;height:14px;width:2px;background:var(--action-teal)}\n.fork2{max-width:360px}\n.node.end small{color:#fff;opacity:.92}\n.dn{color:#6f7c1f;font-weight:600}\n.node.end .dn{color:#ccdb44}\n.note-box.has-bg ul{list-style:none;padding:0;display:grid;gap:12px;max-width:80ch}\n.note-box.has-bg li{position:relative;padding-left:20px;font-size:17.5px;line-height:1.6;color:#fff}\n.note-box.has-bg li::before{content:\"\";position:absolute;left:0;top:.7em;width:8px;height:8px;border-radius:50%;background:#ccdb44}\n.specs dd{overflow-wrap:break-word;word-break:normal;hyphens:none}.specs li:first-child{flex:1.6}\n[type=\"button\"]:hover{background-color:transparent;color:var(--teal-head)}\n[type=\"button\"]:focus{background-color:transparent;color:var(--teal-head)}\n<\/style>\n<script type=\"application\/ld+json\">{\"@context\": \"https:\/\/schema.org\", \"@type\": \"FAQPage\", \"mainEntity\": [{\"@type\": \"Question\", \"name\": \"What is Vascutan Plus?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Vascutan Plus combines the Irbesartan and Hydrochlorothiazide molecules in a tablet for oral administration, designed to optimize blood pressure control in patients with hypertension who have not responded sufficiently to a single drug. This medication offers the benefit of two antihypertensive agents with complementary mechanisms of action to improve therapeutic efficacy.\"}}, {\"@type\": \"Question\", \"name\": \"What is Vascutan Plus indicated for?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Vascutan Plus is indicated for the treatment of arterial hypertension in patients who require combination therapy. It is suitable for arterial hypertension (especially in patients who have not achieved the desired control with a single agent), cardiovascular risk management (effective blood pressure control helps reduce the risk of cardiovascular events, including stroke and myocardial infarction) and long-term management (suitable for patients who require combination therapy for sustained blood pressure control).\"}}, {\"@type\": \"Question\", \"name\": \"How does Vascutan Plus work?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Irbesartan is an angiotensin II receptor antagonist that helps relax the blood vessels. Hydrochlorothiazide is a thiazide diuretic that helps reduce blood volume, which lowers blood pressure and reduces the workload of the heart.\"}}, {\"@type\": \"Question\", \"name\": \"How is Vascutan Plus dosed and administered?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Dosage should be adjusted individually according to the patient\u2019s blood pressure response and tolerance. Typical starting dose: one tablet of Irbesartan 150 mg \/ Hydrochlorothiazide 12.5 mg once daily. May be increased to Irbesartan 300 mg \/ Hydrochlorothiazide 25 mg according to the patient\u2019s need and tolerance. Can be taken with or without food.\"}}, {\"@type\": \"Question\", \"name\": \"What are the benefits of Vascutan Plus?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"The combination of Irbesartan and Hydrochlorothiazide improves efficacy in lowering blood pressure more than either component alone. Reduces the number of tablets needed, improving the patient\u2019s adherence to treatment.\"}}, {\"@type\": \"Question\", \"name\": \"What are the clinical considerations for Vascutan Plus?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Evaluate blood pressure and renal function before starting treatment and monitor regularly. Start treatment only after evaluating the patient\u2019s fluid volume and electrolyte balance. Adjust the dose based on the patient\u2019s blood pressure response and tolerance.\"}}, {\"@type\": \"Question\", \"name\": \"What are the safety and precautionary measures for Vascutan Plus?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Monitor electrolyte levels and renal function due to the risk of dehydration and electrolyte imbalances caused by the diuretic. Caution in patients with renal or hepatic diseases. Contraindicated in patients with hypersensitivity to any component of the product, anuria, or hypersensitivity to sulfonamide-derived drugs. Do not coadminister aliskiren with Vascutan Plus in patients with diabetes.\"}}, {\"@type\": \"Question\", \"name\": \"Which strengths and presentation are available?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Vascutan Plus is available as Irbesartan 150 mg \/ Hydrochlorothiazide 12.5 mg and Irbesartan 300 mg \/ Hydrochlorothiazide 25 mg, in a box of 30 or 100 tablets, following the United States Pharmacopeia standard.\"}}, {\"@type\": \"Question\", \"name\": \"How is Vascutan Plus manufactured?\", \"acceptedAnswer\": {\"@type\": \"Answer\", \"text\": \"Vascutan Plus is manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality. Crassula Pharma certifies that all its products are manufactured in accordance with GMP parameters.\"}}]}<\/script>\n<\/head>\n<body class=\"no-js\">\n<a class=\"skip\" href=\"#main\">Skip to content<\/a>\n<span id=\"top\"><\/span>\n\n\n<main id=\"main\">\n<section class=\"hero\" aria-labelledby=\"h1\" style=\"padding:0\">\n  <canvas id=\"fx\" aria-hidden=\"true\"><\/canvas>\n  <div class=\"cx-wrap\">\n    <div class=\"hero-copy\">\n      <span class=\"tag\">ARB + Thiazide Diuretic \u00b7 Hypertension<\/span>\n      <h1 id=\"h1\">Vascutan Plus<sup>\u00ae<\/sup><\/h1>\n      <p class=\"generic\">Irbesartan \/ Hydrochlorothiazide<\/p>\n      <div class=\"strengths\" role=\"list\">\n        <span class=\"chip t\" role=\"listitem\">150 mg \/ 12.5 mg<\/span>\n        <span class=\"chip g\" role=\"listitem\">300 mg \/ 25 mg<\/span>\n      <\/div>\n      <div class=\"cta-row\">\n        <a class=\"btn btn-primary\" href=\"#mechanism\">Pharmacological Properties<\/a>\n      <\/div>\n    <\/div>\n    <div class=\"hero-art\">\n      <img fetchpriority=\"high\" decoding=\"async\" class=\"a\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/box-vascutan-plus-150.png\" alt=\"Vascutan Plus irbesartan \/ hydrochlorothiazide 150 mg \/ 12.5 mg box\" width=\"568\" height=\"387\" title=\"\">\n      <img decoding=\"async\" class=\"b\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/box-vascutan-plus-300.png\" alt=\"Vascutan Plus irbesartan \/ hydrochlorothiazide 300 mg \/ 25 mg box\" width=\"631\" height=\"454\" title=\"\">\n    <\/div>\n  <\/div>\n<\/section>\n\n<div class=\"specs\">\n  <div class=\"cx-wrap\">\n    <ul>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><rect x=\"2.5\" y=\"8\" width=\"19\" height=\"8\" rx=\"4\"\/><path d=\"M12 8v8\"\/><\/svg><\/span><dl><dt>Active ingredients<\/dt><dd>Irbesartan + Hydrochlorothiazide<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 12c-2-3-3.5-4-5.5-4a4 4 0 0 0 0 8c2 0 3.5-1 5.5-4Zm0 0c2 3 3.5 4 5.5 4a4 4 0 0 0 0-8c-2 0-3.5 1-5.5 4Z\"\/><\/svg><\/span><dl><dt>Strength<\/dt><dd>150 mg \/ 12.5 mg \u00b7 300 mg \/ 25 mg<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M21 8 12 3 3 8v8l9 5 9-5V8Z\"\/><path d=\"m3 8 9 5 9-5M12 13v8\"\/><\/svg><\/span><dl><dt>Presentation<\/dt><dd>Box of 30 or 100 tablets<\/dd><\/dl><\/li>\n      <li><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><rect x=\"5\" y=\"3\" width=\"14\" height=\"18\" rx=\"3\"\/><path d=\"M9 8h6M9 12h6M9 16h3\"\/><\/svg><\/span><dl><dt>Standard<\/dt><dd>USP<\/dd><\/dl><\/li>\n    <\/ul>\n  <\/div>\n<\/div>\n\n<section class=\"about\" aria-labelledby=\"what\">\n  <div class=\"cx-wrap split\">\n    <div class=\"prose rv\">\n    <h2 class=\"h2\" id=\"what\">What is Vascutan Plus?<\/h2>\n    <p><strong>Vascutan Plus<\/strong> combines the Irbesartan and Hydrochlorothiazide molecules in a tablet for oral administration, designed to optimize blood pressure control in patients with hypertension who have not responded sufficiently to a single drug. This medication offers the benefit of two antihypertensive agents with complementary mechanisms of action to improve therapeutic efficacy.<\/p>\n    <\/div>\n    <div class=\"media-wrap rv\" style=\"--d:1\"><div class=\"media\"><img loading=\"lazy\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/info-vascutan-plus.jpg\" alt=\"\" width=\"1600\" height=\"1200\" loading=\"lazy\" decoding=\"async\" title=\"\"><\/div><\/div>\n  <\/div>\n<\/section>\n\n<section class=\"indications\" id=\"indications\" aria-labelledby=\"ind\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"ind\">Indications<\/h2>\n    <p class=\"lead rv\">Vascutan Plus is indicated for the treatment of arterial hypertension in patients who require combination therapy. It is suitable for use in the following conditions:<\/p>\n    <div class=\"cards c3\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M3 12h4l2.500-6 4 12 2.500-6h5\"\/><\/svg><\/span><h3>Arterial Hypertension<\/h3><\/div>\n        <p>Especially in patients who have not achieved the desired control with a single agent.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 20s-7-4.500-7-10a4 4 0 0 1 7-2.500A4 4 0 0 1 19 10c0 5.500-7 10-7 10Z\"\/><path d=\"M8.500 11h2l1-2 1.500 4 1-2h1.500\"\/><\/svg><\/span><h3>Cardiovascular Risk Management<\/h3><\/div>\n        <p>Effective blood pressure control helps reduce the risk of cardiovascular events, including stroke and myocardial infarction.<\/p>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9\"\/><path d=\"M12 7v5l3 2\"\/><\/svg><\/span><h3>Long-Term Management<\/h3><\/div>\n        <p>Suitable for patients who require combination therapy for sustained blood pressure control.<\/p>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"presentations\" id=\"presentations\" aria-labelledby=\"pres\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"pres\">Presentation<\/h2>\n    <div class=\"pres\">\n      <article class=\"pcard rv\" style=\"--c:var(--action-teal);--d:0\">\n        <div class=\"dose\">150\/12.5<small>mg<\/small><\/div>\n        <div><h3>Irbesartan 150 mg \/ Hydrochlorothiazide 12.5 mg<\/h3><p>Box of 30 or 100 tablets \u00b7 United States Pharmacopeia<\/p><\/div>\n      <\/article>\n      <article class=\"pcard a2 rv\" style=\"--d:1\">\n        <div class=\"dose\">300\/25<small>mg<\/small><\/div>\n        <div><h3>Irbesartan 300 mg \/ Hydrochlorothiazide 25 mg<\/h3><p>Box of 30 or 100 tablets \u00b7 United States Pharmacopeia<\/p><\/div>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section id=\"mechanism\" aria-labelledby=\"moa\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"moa\">Pharmacological Properties<\/h2>\n    <div class=\"mech-grid\">\n      <ol class=\"steps\" id=\"steps\">\n        <li class=\"rv\"><span class=\"num\">1<\/span><h3>Irbesartan<\/h3><p>Irbesartan is an angiotensin II receptor antagonist that helps relax the blood vessels.<\/p><\/li>\n        <li class=\"rv\"><span class=\"num\">2<\/span><h3>Hydrochlorothiazide<\/h3><p>Hydrochlorothiazide is a thiazide diuretic that helps reduce blood volume, which lowers blood pressure and reduces the workload of the heart.<\/p><\/li>\n      <\/ol>\n\n      <div class=\"flow\" id=\"flow\" role=\"group\" aria-label=\"How Vascutan Plus works\">\n        <p class=\"flow-title\">How Vascutan Plus works<\/p>\n        <span class=\"node primary\" style=\"--i:0\">Vascutan Plus\u00ae<\/span>\n        <div class=\"fork\" style=\"--i:1;max-width:360px\"><i><\/i><i><\/i><\/div>\n        <div class=\"cols\">\n          <div class=\"col\">\n            <span class=\"node blue\" style=\"--i:2\">Irbesartan<\/span>\n            <div class=\"link-v\" style=\"--i:3\"><\/div>\n            <span class=\"node\" style=\"--i:4\">Angiotensin II receptor antagonist<\/span>\n            <div class=\"link-v\" style=\"--i:5\"><\/div>\n            <span class=\"node\" style=\"--i:6\">Relaxes blood vessels<\/span>\n            <div class=\"link-v nohead\" style=\"--i:7\"><\/div>\n          <\/div>\n          <div class=\"col\">\n            <span class=\"node lime\" style=\"--i:2\">Hydrochlorothiazide<\/span>\n            <div class=\"link-v\" style=\"--i:3\"><\/div>\n            <span class=\"node\" style=\"--i:4\">Thiazide diuretic<\/span>\n            <div class=\"link-v\" style=\"--i:5\"><\/div>\n            <span class=\"node\" style=\"--i:6\"><span class=\"dn\">\u2193<\/span> Blood volume<\/span>\n            <div class=\"link-v nohead\" style=\"--i:7\"><\/div>\n          <\/div>\n        <\/div>\n        <div class=\"join\" style=\"--i:8\"><\/div>\n        <div style=\"height:14px\"><\/div>\n        <span class=\"node end\" style=\"--i:9\"><span class=\"dn\">\u2193<\/span> Blood pressure<small><span class=\"dn\">\u2193<\/span> Workload of the heart<\/small><\/span>\n      <\/div>\n    <\/div>\n\n    <div class=\"cards c2\" style=\"margin-top:56px\">\n      <article class=\"card rv\" style=\"--d:0\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9\"\/><path d=\"M12 7v5l3 2\"\/><\/svg><\/span><h3>Dosage and Administration<\/h3><\/div>\n        <ul><li>Dosage should be adjusted individually according to the patient\u2019s blood pressure response and tolerance.<\/li><li>Typical starting dose: one tablet of Irbesartan 150 mg \/ Hydrochlorothiazide 12.5 mg once daily.<\/li><li>May be increased to Irbesartan 300 mg \/ Hydrochlorothiazide 25 mg according to the patient\u2019s need and tolerance.<\/li><li>Can be taken with or without food.<\/li><\/ul>\n      <\/article>\n      <article class=\"card rv\" style=\"--d:1\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><rect x=\"2.500\" y=\"8\" width=\"19\" height=\"8\" rx=\"4\"\/><path d=\"M12 8v8\"\/><\/svg><\/span><h3>Benefits of Vascutan Plus<\/h3><\/div>\n        <ul><li>The combination of Irbesartan and Hydrochlorothiazide improves efficacy in lowering blood pressure more than either component alone.<\/li><li>Reduces the number of tablets needed, improving the patient\u2019s adherence to treatment.<\/li><\/ul>\n      <\/article>\n      <article class=\"card wide rv\" style=\"--d:2\">\n        <div class=\"card-h\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M9 3h6M10 3v6l-5 9a2 2 0 0 0 1.800 3h10.400a2 2 0 0 0 1.800-3l-5-9V3\"\/><path d=\"M7.500 15h9\"\/><\/svg><\/span><h3>Clinical Considerations<\/h3><\/div>\n        <ul><li>Evaluate blood pressure and renal function before starting treatment and monitor regularly.<\/li><li>Start treatment only after evaluating the patient\u2019s fluid volume and electrolyte balance.<\/li><li>Adjust the dose based on the patient\u2019s blood pressure response and tolerance.<\/li><\/ul>\n      <\/article>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"note\" aria-labelledby=\"imp\">\n  <div class=\"cx-wrap\">\n    <div class=\"note-box has-bg rv\" style=\"--ov:14,30,62\">\n      <div class=\"bg\" aria-hidden=\"true\"><img loading=\"lazy\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/info-vascutan-plus.jpg\" alt=\"\" width=\"1600\" height=\"1200\" loading=\"lazy\" decoding=\"async\" title=\"\"><\/div>\n      <h3 id=\"imp\"><span class=\"ico\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><path d=\"M12 3 2.500 20h19L12 3Z\"\/><path d=\"M12 10v4.500M12 17.200v.1\"\/><\/svg><\/span>Safety and Precautionary Measures<\/h3>\n      <ul>\n        <li>Monitor electrolyte levels and renal function due to the risk of dehydration and electrolyte imbalances caused by the diuretic.<\/li>\n        <li>Caution in patients with renal or hepatic diseases.<\/li>\n        <li>Contraindicated in patients with hypersensitivity to any component of the product, anuria, or hypersensitivity to sulfonamide-derived drugs. Do not coadminister aliskiren with Vascutan Plus in patients with diabetes.<\/li>\n      <\/ul>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"faq\" id=\"faq\" aria-labelledby=\"faq-h\">\n  <div class=\"cx-wrap\">\n    <h2 class=\"h2 rv\" id=\"faq-h\">Frequently Asked Questions<\/h2>\n    <div class=\"faq-list\">\n      <div class=\"faq-item rv\" style=\"--d:0\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q1\" aria-expanded=\"false\" aria-controls=\"faq-a1\"><span>What is Vascutan Plus?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a1\" role=\"region\" aria-labelledby=\"faq-q1\"><div><p><strong>Vascutan Plus<\/strong> combines the Irbesartan and Hydrochlorothiazide molecules in a tablet for oral administration, designed to optimize blood pressure control in patients with hypertension who have not responded sufficiently to a single drug. This medication offers the benefit of two antihypertensive agents with complementary mechanisms of action to improve therapeutic efficacy.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:1\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q2\" aria-expanded=\"false\" aria-controls=\"faq-a2\"><span>What is Vascutan Plus indicated for?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a2\" role=\"region\" aria-labelledby=\"faq-q2\"><div><p>Vascutan Plus is indicated for the treatment of arterial hypertension in patients who require combination therapy. It is suitable for arterial hypertension (especially in patients who have not achieved the desired control with a single agent), cardiovascular risk management (effective blood pressure control helps reduce the risk of cardiovascular events, including stroke and myocardial infarction) and long-term management (suitable for patients who require combination therapy for sustained blood pressure control).<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:2\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q3\" aria-expanded=\"false\" aria-controls=\"faq-a3\"><span>How does Vascutan Plus work?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a3\" role=\"region\" aria-labelledby=\"faq-q3\"><div><p>Irbesartan is an angiotensin II receptor antagonist that helps relax the blood vessels. Hydrochlorothiazide is a thiazide diuretic that helps reduce blood volume, which lowers blood pressure and reduces the workload of the heart.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:3\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q4\" aria-expanded=\"false\" aria-controls=\"faq-a4\"><span>How is Vascutan Plus dosed and administered?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a4\" role=\"region\" aria-labelledby=\"faq-q4\"><div><p>Dosage should be adjusted individually according to the patient\u2019s blood pressure response and tolerance. Typical starting dose: one tablet of Irbesartan 150 mg \/ Hydrochlorothiazide 12.5 mg once daily. May be increased to Irbesartan 300 mg \/ Hydrochlorothiazide 25 mg according to the patient\u2019s need and tolerance. Can be taken with or without food.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q5\" aria-expanded=\"false\" aria-controls=\"faq-a5\"><span>What are the benefits of Vascutan Plus?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a5\" role=\"region\" aria-labelledby=\"faq-q5\"><div><p>The combination of Irbesartan and Hydrochlorothiazide improves efficacy in lowering blood pressure more than either component alone. Reduces the number of tablets needed, improving the patient\u2019s adherence to treatment.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q6\" aria-expanded=\"false\" aria-controls=\"faq-a6\"><span>What are the clinical considerations for Vascutan Plus?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a6\" role=\"region\" aria-labelledby=\"faq-q6\"><div><p>Evaluate blood pressure and renal function before starting treatment and monitor regularly. Start treatment only after evaluating the patient\u2019s fluid volume and electrolyte balance. Adjust the dose based on the patient\u2019s blood pressure response and tolerance.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q7\" aria-expanded=\"false\" aria-controls=\"faq-a7\"><span>What are the safety and precautionary measures for Vascutan Plus?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a7\" role=\"region\" aria-labelledby=\"faq-q7\"><div><p>Monitor electrolyte levels and renal function due to the risk of dehydration and electrolyte imbalances caused by the diuretic. Caution in patients with renal or hepatic diseases. Contraindicated in patients with hypersensitivity to any component of the product, anuria, or hypersensitivity to sulfonamide-derived drugs. Do not coadminister aliskiren with Vascutan Plus in patients with diabetes.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q8\" aria-expanded=\"false\" aria-controls=\"faq-a8\"><span>Which strengths and presentation are available?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a8\" role=\"region\" aria-labelledby=\"faq-q8\"><div><p>Vascutan Plus is available as Irbesartan 150 mg \/ Hydrochlorothiazide 12.5 mg and Irbesartan 300 mg \/ Hydrochlorothiazide 25 mg, in a box of 30 or 100 tablets, following the United States Pharmacopeia standard.<\/p><\/div><\/div>\n      <\/div>\n      <div class=\"faq-item rv\" style=\"--d:4\">\n        <h3><button class=\"faq-q\" type=\"button\" id=\"faq-q9\" aria-expanded=\"false\" aria-controls=\"faq-a9\"><span>How is Vascutan Plus manufactured?<\/span><span class=\"faq-ico\" aria-hidden=\"true\"><svg viewBox=\"0 0 16 16\"><path d=\"M8 2v12M2 8h12\"\/><\/svg><\/span><\/button><\/h3>\n        <div class=\"faq-a\" id=\"faq-a9\" role=\"region\" aria-labelledby=\"faq-q9\"><div><p>Vascutan Plus is manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality. Crassula Pharma certifies that all its products are manufactured in accordance with GMP parameters.<\/p><\/div><\/div>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n\n<section class=\"quality\" id=\"quality\" aria-labelledby=\"qs\">\n  <div class=\"cx-wrap\">\n    <div class=\"qbox rv\">\n      <h2 id=\"qs\">Quality &amp; Standards<\/h2>\n      <div class=\"qgrid\">\n        <img decoding=\"async\" class=\"gmp\" src=\"https:\/\/crassulapharma.com\/wp-content\/uploads\/2026\/10\/logo-gmp.png\" alt=\"GMP Certified Quality\" width=\"112\" height=\"112\" title=\"\">\n        <div class=\"check\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9.5\"\/><path d=\"m8 12.5 2.7 2.7L16 9.5\"\/><\/svg><p>Manufactured according to the strict specifications of the United States Pharmacopeia to ensure consistency and superior quality.<\/p><\/div>\n        <div class=\"check\"><svg viewBox=\"0 0 24 24\" aria-hidden=\"true\"><circle cx=\"12\" cy=\"12\" r=\"9.5\"\/><path d=\"m8 12.5 2.7 2.7L16 9.5\"\/><\/svg><p>Crassula Pharma certifies that all our products are manufactured in accordance with GMP parameters.<\/p><\/div>\n      <\/div>\n    <\/div>\n  <\/div>\n<\/section>\n<\/main>\n\n\n<script>\n(function(){\n  var d=document.documentElement,b=document.body;\n  b.classList.remove('no-js');\n  requestAnimationFrame(function(){requestAnimationFrame(function(){b.classList.add('loaded')})});\n\n  var io=new IntersectionObserver(function(es){es.forEach(function(e){\n    if(e.isIntersecting){e.target.classList.add('in');io.unobserve(e.target)}})},{threshold:.15,rootMargin:'0px 0px -6% 0px'});\n  document.querySelectorAll('.rv').forEach(function(el){io.observe(el)});\n\n\n  (function(){\n    var c=document.getElementById('fx');if(!c||!c.getContext)return;\n    var ctx=c.getContext('2d'),hero=c.parentElement,W=0,H=0,dpr=1,P=[],run=false,raf=0,mx=-999,my=-999;\n    var reduce=matchMedia('(prefers-reduced-motion: reduce)').matches;\n    function size(){var r=hero.getBoundingClientRect();dpr=Math.min(devicePixelRatio||1,2);W=r.width;H=r.height;c.width=W*dpr;c.height=H*dpr;ctx.setTransform(dpr,0,0,dpr,0,0);\n      var n=Math.round(Math.min(90,Math.max(28,W*H\/16000)));P=[];\n      for(var i=0;i<n;i++)P.push({x:Math.random()*W,y:Math.random()*H,vx:(Math.random()-.5)*.28,vy:(Math.random()-.5)*.28,r:Math.random()*1.4+.8});}\n    function draw(){\n      ctx.clearRect(0,0,W,H);var L=Math.min(150,W\/7);\n      for(var i=0;i<P.length;i++){var a=P[i];\n        if(!reduce){a.x+=a.vx;a.y+=a.vy;if(a.x<0||a.x>W)a.vx*=-1;if(a.y<0||a.y>H)a.vy*=-1;\n          var dx=a.x-mx,dy=a.y-my,d=dx*dx+dy*dy;if(d<14400){var f=(1-Math.sqrt(d)\/120)*.6;a.x+=dx*f*.02;a.y+=dy*f*.02}}\n        for(var j=i+1;j<P.length;j++){var b=P[j],ex=a.x-b.x,ey=a.y-b.y,e=ex*ex+ey*ey;\n          if(e<L*L){ctx.strokeStyle='rgba(224,196,236,'+(.22*(1-Math.sqrt(e)\/L))+')';ctx.lineWidth=1;ctx.beginPath();ctx.moveTo(a.x,a.y);ctx.lineTo(b.x,b.y);ctx.stroke()}}\n        ctx.fillStyle='rgba(240,222,247,.75)';ctx.beginPath();ctx.arc(a.x,a.y,a.r,0,6.2832);ctx.fill();}\n      if(run&&!reduce)raf=requestAnimationFrame(draw);}\n    function start(){if(!run){run=true;raf=requestAnimationFrame(draw)}}\n    function stop(){run=false;cancelAnimationFrame(raf)}\n    size();draw();\n    var rt;addEventListener('resize',function(){clearTimeout(rt);rt=setTimeout(function(){size();draw()},150)});\n    hero.addEventListener('pointermove',function(e){var r=hero.getBoundingClientRect();mx=e.clientX-r.left;my=e.clientY-r.top},{passive:true});\n    hero.addEventListener('pointerleave',function(){mx=my=-999});\n    new IntersectionObserver(function(es){es[0].isIntersecting?start():stop()}).observe(hero);\n  })();\n\n  document.querySelectorAll('.faq-q').forEach(function(b){\n    b.addEventListener('click',function(){\n      var it=b.closest('.faq-item'),open=it.classList.toggle('open');\n      b.setAttribute('aria-expanded',open?'true':'false');\n    });\n  });\n  var flow=document.getElementById('flow');\n  var fio=new IntersectionObserver(function(es){es.forEach(function(e){if(e.isIntersecting){flow.classList.add('in');fio.disconnect()}})},{threshold:.25});\n  fio.observe(flow);\n\n  var steps=document.getElementById('steps');\n  function line(){var r=steps.getBoundingClientRect(),h=innerHeight;\n    var p=Math.min(1,Math.max(0,(h*.75-r.top)\/r.height));steps.style.setProperty('--line',p)}\n  addEventListener('scroll',line,{passive:true});line();\n\n})();\n<\/script>\n<\/body>\n<\/html>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Vascutan Plus\u00ae (Irbesartan \/ Hydrochlorothiazide) \u2013 Crassula Skip to content ARB + Thiazide Diuretic \u00b7 Hypertension Vascutan Plus\u00ae Irbesartan \/ Hydrochlorothiazide 150 mg \/ 12.5 mg 300 mg \/ 25 mg Pharmacological Properties Active ingredients Irbesartan + Hydrochlorothiazide Strength 150 mg \/ 12.5 mg \u00b7 300 mg \/ 25 mg Presentation Box of 30 or [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_uf_show_specific_survey":0,"_uf_disable_surveys":false,"footnotes":""},"class_list":["post-12056","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/12056","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/comments?post=12056"}],"version-history":[{"count":4,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/12056\/revisions"}],"predecessor-version":[{"id":12065,"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/pages\/12056\/revisions\/12065"}],"wp:attachment":[{"href":"https:\/\/crassulapharma.com\/es\/wp-json\/wp\/v2\/media?parent=12056"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}